US Stem Cell Inc (USRM)

[The Night Stalker]

? Revenue growth has increased from $96 thousand in 2013 to $1.54 million in 2014 and increased another 25% in the first quarter 2015 quarter over quarter.
? Liabilities were reduced by 20% from December 31, 2013 to December 31, 2014 from $13.4 million to
$11.1 million and again reduced an additional $100 thousand in the first quarter of 2015.
? Working capital deficit improved 20% from 2013 to 2014 year over year.
? Net loss was reduced 48% from 2013 to 2014 and remained stable in the first quarter of 2015
? Cash used for operating expenses were reduced 42% from 2013 to 2014 from $1.9 million to $1.1 million year over year.
Our strategic initiatives include, but are not limited to: